Among these genes, PRL-3 (PTP4A3) was the most frequently overexpressed across cancer types, including colorectal, gastric, bladder, and breast cancers (Figure 1A), consistent with previous studies linking PRL-3 to cancer progression. The gene discussed is PTP4A3; the disease is breast cancer.